Minerva Neurosciences

Minerva Neurosciences

Pharmaceuticals, 1601 Trapelo Rd, Waltham, Massachusetts, 02451, United States, 10001+ Employees

minervaneurosciences.com

  • facebook
  • LinkedIn

phone no Phone Number: 61********

Who is MINERVA NEUROSCIENCES

Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on the development of a portfolio of product candidates to treat central nervous system (C...

Read More

map
  • 1601 Trapelo Rd, Waltham, Massachusetts, 02451, United States Headquarters: 1601 Trapelo Rd, Waltham, Massachusetts, 02451, United States
  • 10001+ Employees: 10001+
  • dollar-icon Revenue: $10 Million to $25 Million
  • Remy Luthringer CEO:   Remy Luthringer

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from MINERVA NEUROSCIENCES

Minerva Neurosciences Org Chart and Mapping

Employees

Joe Reilly

Chief Operating Officer

Frederick Ahlholm

Chief Financial Officer and Secretary

Anthony Aliquo

Vice President, Controller

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Minerva Neurosciences

Answer: Minerva Neurosciences's headquarters are located at 1601 Trapelo Rd, Waltham, Massachusetts, 02451, United States

Answer: Minerva Neurosciences's phone number is 61********

Answer: Minerva Neurosciences's official website is https://minervaneurosciences.com

Answer: Minerva Neurosciences's revenue is $10 Million to $25 Million

Answer: Minerva Neurosciences's SIC: 2834

Answer: Minerva Neurosciences has 10001+ employees

Answer: Minerva Neurosciences is in Pharmaceuticals

Answer: Minerva Neurosciences contact info: Phone number: 61******** Website: https://minervaneurosciences.com

Answer: Minerva Neurosciences, Inc. (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on the development of a portfolio of product candidates to treat central nervous system (CNS) diseases. Our goal is to transform the lives of patients with improved therapeutic options. Leveraging extensive domain expertise, we have identified and acquired or in-licensed a portfolio of development-stage proprietary compounds with what we believe are innovative mechanisms of action. Our executive management team includes globally recognized specialists in central nervous system diseases addressing significant unmet medical needs.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access